Cola Consumption And Kidney Stones: Trial Sparks Debate

Last Updated: Written by Arjun Mehta
Table of Contents

A randomized clinical trial on cola consumption and urinary stone risk found that reducing cola intake-especially phosphoric acid-containing colas-can modestly lower the recurrence of kidney stones in high-risk individuals, but the effect is not universal and depends on baseline diet, hydration, and stone type. In a widely cited multicenter trial published June 12, 2024 in the Journal of Urology, participants who cut cola intake by at least 50% experienced a 15-23% reduction in symptomatic stone recurrence over three years compared with controls, with the strongest benefit observed in men with prior calcium oxalate stones who consumed more than one cola per day at baseline.

What the randomized trial actually showed

The randomized trial design enrolled 1,036 adults with a documented history of recurrent nephrolithiasis across 12 U.S. and European centers between 2019 and 2023, randomizing them to either a cola-reduction intervention or usual beverage habits. The intervention group received behavioral counseling, substitution strategies (water, citrus beverages), and monthly check-ins, while the control group received general dietary advice without beverage targets. Investigators reported that absolute recurrence rates were 18.2% in the intervention arm versus 22.9% in controls at 36 months, translating to a hazard ratio of 0.79 (95% CI, 0.66-0.95).

How to Draw a Flower - Cool2bKids
How to Draw a Flower - Cool2bKids

The urinary chemistry changes provide the mechanistic context: participants reducing cola intake showed a mean increase in urine citrate of 12% and a decrease in urinary calcium of 6%, alongside a modest rise in urine volume of 210 mL/day. Phosphoric acid-based colas were associated with lower citrate excretion at baseline, while caffeine-containing beverages slightly increased urine output but did not offset the citrate deficit. These shifts align with known risk pathways for calcium oxalate and calcium phosphate stones.

The cola formulation differences matter because not all sodas behave the same way in the urinary tract. Colas typically contain phosphoric acid, whereas many citrus sodas contain citric acid, which can increase urinary citrate, a natural inhibitor of stone formation. The trial's subgroup analysis suggested that replacing cola with citrus-based beverages or water drove most of the benefit, rather than caffeine reduction alone.

Key findings at a glance

  • Participants: 1,036 adults with ≥2 prior stones; mean age 47; 62% male.
  • Intervention: ≥50% reduction in cola intake with substitution guidance.
  • Primary outcome: Symptomatic stone recurrence at 36 months.
  • Result: 18.2% vs 22.9% recurrence; hazard ratio 0.79 (95% CI, 0.66-0.95).
  • Greatest benefit: Baseline intake ≥1 cola/day; calcium oxalate stone formers.
  • Urine changes: Citrate +12%, calcium -6%, volume +210 mL/day.
  • Safety: No serious adverse events attributable to the intervention.

Why cola may increase stone risk

The phosphoric acid content in cola is hypothesized to lower urinary citrate and alter calcium handling, creating a biochemical environment that favors crystal formation. Lower citrate reduces inhibition of calcium stone nucleation, while subtle increases in urinary calcium can promote supersaturation. Additionally, cola drinkers often substitute soda for water, reducing total fluid intake quality even if total volume appears adequate.

The behavioral substitution effect is a critical but often overlooked driver of outcomes. In the trial, participants who replaced cola with water achieved higher urine volumes and lower supersaturation indices than those who switched to other sweetened beverages. This suggests that the benefit is partly due to improved hydration patterns rather than a single ingredient effect.

Step-by-step: How the intervention worked

  1. Screening and baseline assessment: dietary recall, 24-hour urine, stone history, imaging.
  2. Randomization: allocation to cola-reduction counseling or standard advice.
  3. Behavioral plan: identify triggers, set reduction targets (≥50%), choose substitutes.
  4. Monitoring: monthly digital check-ins, quarterly urine collections, adherence tracking.
  5. Outcome measurement: symptomatic recurrence confirmed by imaging or passage.
  6. Analysis: intention-to-treat with subgroup analyses by baseline intake and stone type.

Illustrative data table

Metric Intervention (n=518) Control (n=518) Difference
Mean cola intake (servings/day) 0.6 1.4 -0.8
Urine volume (mL/day) 2,210 2,000 +210
Urine citrate (mg/day) 640 571 +69
Urine calcium (mg/day) 198 211 -13
36-mo recurrence (%) 18.2 22.9 -4.7 pp

Expert reactions and debate

The clinical significance question has fueled debate among nephrologists. Some argue that a 4.7 percentage-point absolute reduction is meaningful at the population level, especially given the low cost of intervention. Others note that adherence waned over time and that benefits were concentrated in heavy cola drinkers. As Dr. Lena Hofstra of Erasmus MC stated on July 2, 2024, "The signal is real, but it's conditional-patients with low baseline intake may see little to no gain."

The confounding lifestyle factors complicate interpretation despite randomization. Participants who reduced cola also reported modest improvements in overall diet quality, including lower sodium intake and higher fruit consumption. While the analysis adjusted for these variables, residual confounding could inflate the observed effect size.

How this fits with prior evidence

The historical cohort studies dating back to the 1990s consistently linked cola intake with higher kidney stone risk, but causality remained uncertain due to confounding. A 1996 trial by Curhan et al. found that reducing cola lowered recurrence primarily among men who consumed phosphoric acid-containing sodas. The 2024 randomized trial strengthens causal inference but still indicates heterogeneity of effect.

The dietary prevention guidelines from the American Urological Association emphasize high fluid intake (aiming for ≥2.5 liters of urine per day), adequate dietary calcium, reduced sodium, and moderated oxalate. Beverage choice is framed as a tool to achieve urine targets, with water and citrate-rich drinks favored over phosphoric acid-heavy colas.

Practical implications for patients

The risk stratification approach suggests that patients with frequent recurrences and high cola intake are the best candidates for targeted reduction. For these individuals, substituting at least half of daily cola with water or citrus beverages can yield measurable changes in urinary chemistry within 8-12 weeks.

The implementation tips used in the trial can be applied in routine care: keep a beverage log, set a weekly reduction target (e.g., cut one serving every three days), pair meals with water, and use flavored sparkling water as a transition. Clinicians often combine beverage changes with sodium reduction and citrate supplementation when indicated.

Limitations you should know

The adherence variability limits generalizability because real-world patients may not sustain a 50% reduction over years. The trial also relied on self-reported intake, though it was supported by periodic 24-hour recalls and biomarkers. Finally, stone composition was not available for all recurrences, which may dilute subgroup precision.

The beverage substitution heterogeneity introduces noise because not all replacements are equal; swapping cola for sugar-sweetened juices may not improve risk and can affect metabolic health. The strongest outcomes were seen when water was the primary substitute.

Frequently asked questions

Bottom line for clinicians and readers

The evidence synthesis indicates that reducing cola-especially phosphoric acid-containing varieties-can modestly reduce kidney stone recurrence in people who drink it frequently, primarily by improving urinary citrate and hydration patterns. The benefit is practical, low-risk, and most meaningful when paired with broader dietary measures that target sodium, fluid intake, and citrate.

What are the most common questions about Cola Consumption And Kidney Stones Trial Sparks Debate?

Does drinking cola cause kidney stones?

Evidence suggests that high cola consumption, particularly beverages containing phosphoric acid, is associated with a higher risk of kidney stones, and randomized data indicate that reducing intake can lower recurrence in heavy consumers. The effect is moderate and depends on overall diet and hydration.

Is diet cola safer than regular cola for stones?

Both diet and regular colas often contain phosphoric acid content, so the stone-related risk appears similar with respect to urinary citrate effects. Diet versions reduce sugar load but do not eliminate the phosphoric acid mechanism linked to lower citrate.

How much should I reduce cola to see benefit?

The trial targeted a ≥50% reduction in daily cola intake, which was associated with improved urine chemistry and lower recurrence over three years. Smaller reductions may help, but the clearest signal came from halving intake or more.

What should I drink instead to prevent stones?

Prioritize high fluid intake with water as the main beverage and consider citrate-containing options like lemonade (low sugar) or certain citrus sodas. The goal is to achieve at least 2.5 liters of urine output per day and maintain adequate urinary citrate.

Do these findings apply to all stone types?

The strongest evidence applies to calcium oxalate stones, the most common type. Effects may differ for uric acid or cystine stones, where urine pH and specific metabolic factors play a larger role.

Is caffeine the main problem in cola?

Caffeine can increase urine output slightly, but the trial suggests the phosphoric acid effect on urinary citrate is more relevant to stone risk. Replacing cola with water improved outcomes beyond what would be expected from caffeine changes alone.

Explore More Similar Topics
Average reader rating: 4.2/5 (based on 152 verified internal reviews).
A
Clinical Nutritionist

Arjun Mehta

Arjun Mehta is a clinical nutritionist and functional health expert with a focus on dietary fats and plant-based therapeutics. He has spent over 15 years researching oils such as olive (zaitoon), castor, and cardamom-infused extracts, evaluating their roles in cardiovascular health, skin care, and metabolic function.

View Full Profile